News Bulletin
Monday, April 13th 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
6:00 |
OPEC Monthly Report |
|
|
|
|
6:00 |
IMF Mettings |
|
|
|
|
10:00 |
Existing Home Sales (Mar) |
3.98M |
4.07M |
4.09M |
|
10:00 |
Existing Home Sales (MoM) (Mar) |
-3.60% |
|
1.70% |
|
11:30 |
3-Month Bill Auction |
3.62% |
|
3.64% |
|
11:30 |
6-Month Bill Auction |
3.61% |
|
3.62% |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
48219.05 |
47978.65 |
46867.41 |
|
NASDAQ |
23183.74 |
22489.73 |
22426.77 |
|
S&P 500 |
6886.21 |
6752.71 |
6668.89 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
NAME |
COMPANY |
Mkt CAP |
EPS (Forcast) |
EPS (Actual) |
Rev (Forcast) |
Rev (Actual) |
Time |
|
RIOFF |
Rio2 |
C$874.40M |
0 |
-$0.017 |
|
0 |
|
|
MRT |
Marti
Technologies |
$160.57M |
-0.29 |
(0%) -$0.29 |
$19.96M |
|
BMO |
|
SIFY |
Sify Technologies |
$994.50M |
0 |
|
$180.42M |
|
BMO |
|
FAST |
Fastenal
Company |
$56.46B |
0.3 |
(+0.33%) +$0.3 |
$2.20B |
(+0.24%) +$2.202B |
BMO |
|
GS |
Goldman
Sachs Group |
$267.80B |
16.47 |
|
$16.99B |
|
BMO |
|
FBK |
FB
Financial |
$2.84B |
1.1 |
|
$175.42M |
|
AMC |
Market News:
U.S. stocks closed mixed Monday, as investors
reacted to escalating geopolitical tensions in the Middle East and rising oil
prices following failed U.S.Iran talks. Energy stocks gained, while financials
and some industrial names lagged.
Here are some of the biggest post-market / closing
movers today:
Oracle (NYSE: ORCL)
surged 11% after strong momentum in its AI-related business outlook boosted
investor sentiment.
Revolution Medicines (NASDAQ: RVMD)
soared 39% following positive Phase 3 clinical trial results for its cancer
treatment.
Leggett & Platt (NYSE: LEG)
jumped 13% after announcing a major all-stock acquisition deal.
Sandisk (NASDAQ: SNDK)
gained 8% after news it will be added to the Nasdaq-100 index.
CoreWeave (NASDAQ: CRWV)
climbed 89% amid continued strength in AI infrastructure demand and analyst
upgrades.
Intel (NASDAQ: INTC) rose
34%, extending its recent rally on improving sentiment in semiconductors.
Goldman Sachs (NYSE: GS) fell
23% despite beating earnings expectations, as investors focused on broader
sector weakness.
Fastenal (NASDAQ: FAST)
dropped 67% after rising costs weighed on margins despite meeting earnings
estimates.
Replimune (NASDAQ: REPL)
plunged 65% after the FDA declined approval for its melanoma treatment.
Chevron (NYSE: CVX)
edged higher 1%, supported by rising oil prices amid geopolitical tensions.
For
internal use only